LÓPEZ VARELA MV; ANIDO T; ROVIRA M; GOJA B; TUBINO M; ALFONSO G; VEZOLI M; GARATEGUY E; BERMÚDEZ F; LÓPEZ SOTO R
Rev Med Urug 2007; 23: 25-33
Full text (spanish) | Full text (spanish) (New windows, pdf) | Abstract
Smoking is the first cause of evitable mortality and morbility in Occident.
Objective: to assess the efficacy of a smoking cessa-tion program and associated risk factors.
Methods: the Program accounted for 517 people, 357 attended at least two sessions. Sex, age, marital status, education level, associated diseases, familial smoking en-vironment, previous attempts of smoking cessation, smok-ing history and dependence assessment using the FagerstrÃ¶m scale were evaluated.
An 8-week multicomponent program was conducted: a cognitive behavior based, a pharmacist based (bupropion or other nicotinic replacement) and group therapy managed.
Abstinence was verified by exhaled carbon monoxide levels.
Results: the population of the program, aged from 20 and 77 years (mean age 50,58 Â± 11,24), were 61,1% women, 82,9% had had previous attempts to stop smoking, smok-ers of 44,22 Â± 26,30 pack/year, mean age of first smoking 17,93 Â± 3,65 years, smoking 28,38 Â± 13,45 cigarettes/day, dependence by FagerstrÃ¶m was 5,99 Â± 2,12, 89,4% were under pharmacological treatment; 113 participants (31,6%) stopped smoking over a year. A smaller rate of smoking cessation is associated with women, higher dependence by FagerstrÃ¶m, and continued smoking in the initial weeks and at three months.
Conclusions: the program reached smoking cessation rates of 31,6% a year, similar to published data of other centers, efficacy is related to sex, nicotine dependence and early cessation, at the begining of the program.